Option Care Health (NASDAQ:OPCH) Rating Lowered to Hold at Jefferies Financial Group

Option Care Health (NASDAQ:OPCH) was downgraded by equities researchers at Jefferies Financial Group from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Thursday, Marketbeat Ratings reports. They presently have a $26.00 price target on the stock, down from their previous price target of $38.00. Jefferies Financial Group’s price target suggests a potential upside of 7.84% from the company’s current price.

OPCH has been the topic of several other reports. Barrington Research reiterated an “outperform” rating and set a $40.00 target price on shares of Option Care Health in a research note on Wednesday, October 23rd. JMP Securities lifted their price target on shares of Option Care Health from $36.00 to $37.00 and gave the stock a “market outperform” rating in a research note on Monday, September 30th. Finally, Bank of America lowered Option Care Health from a “buy” rating to a “neutral” rating and reduced their price objective for the stock from $43.00 to $29.00 in a research note on Wednesday. Two investment analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $31.60.

Option Care Health Stock Up 4.6 %

Shares of Option Care Health stock opened at $24.11 on Thursday. The firm has a market cap of $4.12 billion, a price-to-earnings ratio of 20.26, a PEG ratio of 1.79 and a beta of 1.29. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.73 and a quick ratio of 1.36. Option Care Health has a 1 year low of $22.84 and a 1 year high of $34.63. The company has a 50-day moving average of $30.49 and a 200 day moving average of $29.92.

Option Care Health (NASDAQ:OPCH) last posted its quarterly earnings data on Wednesday, October 30th. The company reported $0.36 earnings per share for the quarter, beating analysts’ consensus estimates of $0.31 by $0.05. Option Care Health had a return on equity of 15.30% and a net margin of 4.37%. The company had revenue of $1.28 billion during the quarter, compared to analyst estimates of $1.22 billion. As a group, sell-side analysts anticipate that Option Care Health will post 1.22 earnings per share for the current fiscal year.

Insider Transactions at Option Care Health

In other Option Care Health news, Director Elizabeth Quadros Betten sold 47,531 shares of the stock in a transaction dated Wednesday, August 21st. The shares were sold at an average price of $31.09, for a total transaction of $1,477,738.79. Following the completion of the transaction, the director now owns 21,339 shares of the company’s stock, valued at $663,429.51. This represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. In other Option Care Health news, Director Elizabeth Quadros Betten sold 47,531 shares of the stock in a transaction on Wednesday, August 21st. The shares were sold at an average price of $31.09, for a total transaction of $1,477,738.79. Following the completion of the transaction, the director now owns 21,339 shares in the company, valued at $663,429.51. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CFO Michael H. Shapiro sold 23,217 shares of the business’s stock in a transaction dated Thursday, August 22nd. The stock was sold at an average price of $30.95, for a total transaction of $718,566.15. Following the completion of the sale, the chief financial officer now owns 247,317 shares in the company, valued at approximately $7,654,461.15. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 0.64% of the company’s stock.

Institutional Investors Weigh In On Option Care Health

A number of institutional investors and hedge funds have recently modified their holdings of the business. Blue Trust Inc. boosted its stake in shares of Option Care Health by 14.8% during the second quarter. Blue Trust Inc. now owns 2,931 shares of the company’s stock valued at $81,000 after purchasing an additional 377 shares during the period. GAMMA Investing LLC boosted its position in Option Care Health by 110.6% in the 3rd quarter. GAMMA Investing LLC now owns 897 shares of the company’s stock valued at $28,000 after buying an additional 471 shares during the period. Trust Point Inc. increased its position in shares of Option Care Health by 2.6% during the third quarter. Trust Point Inc. now owns 24,124 shares of the company’s stock worth $755,000 after acquiring an additional 622 shares during the period. Nisa Investment Advisors LLC boosted its holdings in shares of Option Care Health by 5.4% in the second quarter. Nisa Investment Advisors LLC now owns 13,581 shares of the company’s stock valued at $376,000 after purchasing an additional 690 shares during the period. Finally, State of Alaska Department of Revenue grew its stake in Option Care Health by 3.8% in the third quarter. State of Alaska Department of Revenue now owns 19,871 shares of the company’s stock worth $621,000 after purchasing an additional 735 shares in the last quarter. 98.05% of the stock is owned by institutional investors.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.